Your browser doesn't support javascript.
loading
Interventions aiming to eliminate catastrophic costs due to tuberculosis: a protocol for a systematic review and meta-analysis.
Carballo-Jimenez, Paula P; Datta, Sumona; Aguirre-Ipenza, Rubén; Saunders, Matthew J; Quevedo Cruz, Luz; Evans, Carlton A.
Afiliación
  • Carballo-Jimenez PP; IFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.
  • Datta S; IPSYD: Innovación Por la Salud Y Desarrollo, Asociación Benéfica Prisma, Lima, Peru.
  • Aguirre-Ipenza R; IFHAD: Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Saunders MJ; IFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.
  • Quevedo Cruz L; IPSYD: Innovación Por la Salud Y Desarrollo, Asociación Benéfica Prisma, Lima, Peru.
  • Evans CA; IFHAD: Innovation For Health And Development, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.
Wellcome Open Res ; 7: 92, 2022.
Article en En | MEDLINE | ID: mdl-37224318
ABSTRACT

Background:

People with tuberculosis disease and their household members may suffer direct out-of-pocket expenses and indirect costs of lost income. These tuberculosis-related costs can worsen poverty, make tuberculosis treatment completion unaffordable, impair quality of life and increase the risk of death. Costs due to tuberculosis are usually defined as catastrophic if they exceed 20% of the pre-disease annual household income. The World Health Organisation strategy to "End TB" and the United Nations Sustainable Development Goals include the target that no households should face catastrophic costs due to tuberculosis. However, there is limited evidence and policy concerning how this global priority of eliminating catastrophic costs due to tuberculosis should be achieved. This systematic review and meta-analysis aims to address this knowledge gap.

Methods:

Publications assessing interventions that aimed to eliminate catastrophic costs will be identified by searching three electronic databases (PubMed, Scopus and Web of Science) together with reference lists from pertinent publications. We will screen eligible studies, extract data, and assess the risk of bias with the quality assessment tool from the National Heart, Lung, and Blood Institute. Discrepancies will be resolved by discussion between the reviewers. If we find sufficient comparable studies quantifying strategies to eliminate catastrophic costs then a meta-analysis will be performed. This systematic review and meta-analysis is registered with the PROSPERO database (CRD42022292410).

Conclusion:

This systematic review and meta-analysis aims to rigorously assess the evidence for strategies to eliminate catastrophic costs due to tuberculosis.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Systematic_reviews Idioma: En Revista: Wellcome Open Res Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Systematic_reviews Idioma: En Revista: Wellcome Open Res Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido